15
Participants
Start Date
October 17, 2018
Primary Completion Date
October 1, 2021
Study Completion Date
August 1, 2022
Irofulven
"Irofulven will be administered as an intravenous dose of 0.45 mg/kg, over a 30-minute infusion period by venous access at day 1 and 8 of a three week cycle.~Irofulven will be administered in combination with a daily dose of 10 mg orally administered prednisolone."
Prednisolone 10 mg
"Irofulven will be administered as an intravenous dose of 0.45 mg/kg, over a 30-minute infusion period by venous access at day 1 and 8 of a three week cycle.~Irofulven will be administered in combination with a daily dose of 10 mg orally administered prednisolone."
Rigshospitalet, Dept. Of Oncology, Copenhagen
Lead Sponsor
Collaborators (1)
Smerud Medical Research International AS
OTHER
Lantern Pharma Inc.
INDUSTRY
Allarity Therapeutics
INDUSTRY